Aql, E., Abdallah, O., Abdel Khalik, G., Mohammed, A. (2023). Assessment of Serum level of Apolipoprotein E4 in Patients with Vitiligo: A Comparative Review. Benha Journal of Applied Sciences, 8(8), 29-37. doi: 10.21608/bjas.2023.227673.1222
Essam Aql; Omnia Abdallah; Ghada Abdel Khalik; Asmaa Mohammed. "Assessment of Serum level of Apolipoprotein E4 in Patients with Vitiligo: A Comparative Review". Benha Journal of Applied Sciences, 8, 8, 2023, 29-37. doi: 10.21608/bjas.2023.227673.1222
Aql, E., Abdallah, O., Abdel Khalik, G., Mohammed, A. (2023). 'Assessment of Serum level of Apolipoprotein E4 in Patients with Vitiligo: A Comparative Review', Benha Journal of Applied Sciences, 8(8), pp. 29-37. doi: 10.21608/bjas.2023.227673.1222
Aql, E., Abdallah, O., Abdel Khalik, G., Mohammed, A. Assessment of Serum level of Apolipoprotein E4 in Patients with Vitiligo: A Comparative Review. Benha Journal of Applied Sciences, 2023; 8(8): 29-37. doi: 10.21608/bjas.2023.227673.1222
Assessment of Serum level of Apolipoprotein E4 in Patients with Vitiligo: A Comparative Review
1Dermatology, Venereology and Andrology Dept., Faculty of Medicine, Benha University
2medical biochemistry and molecular biology Dept., Faculty of Medicine, Benha University
Abstract
Background: Vitiligo is an acquired autoimmune disorder characterized by patchy depigmentation in the skin and hair. Dysregulation of lipid metabolism and immune dysregulation are key factors in the pathogenesis of vitiligo. Apolipoprotein E4 (ApoE4), a protein involved in lipid metabolism, has been implicated in various health conditions. Assessing serum levels of ApoE4 in patients with vitiligo may provide insights into the disease process and clinical implications. 1.Introduction Vitiligo is an acquired, idiopathic, auto-immune condition characterised by patchy depigmentation of the skin, hair, or both. This illness affects a considerable fraction of the worldwide population, with an estimated frequency among adults and children of 0.5-2 %. Vitiligo is characterised by the emergence of amelanotic, milky white macules or patches with well-defined boundaries, surrounded by unaffected skin Objective: The review aims to explore the potential role of ApoE4 in vitiligo pathogenesis, its association with lipid metabolism and immune dysregulation, and the clinical implications of altered ApoE4 levels. Conclusions: In conclusion, the assessment of serum levels of Apolipoprotein E4 (ApoE4) in patients with vitiligo holds promise as a potential avenue for understanding the disease and its clinical implications.
View on SCiNiTO
Top